🇨🇦 Dosing Interruption of Natalizumab in Canada

Dosing Interruption of Natalizumab (Dosing Interruption of Natalizumab) regulatory status in Canada.

Marketing authorisation

Dosing Interruption of Natalizumab in other countries

Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.

Frequently asked questions

Is Dosing Interruption of Natalizumab approved in Canada?

Yes. Health Canada has authorised it.

Who is the marketing authorisation holder for Dosing Interruption of Natalizumab in Canada?

Berkovich, Regina MD, PhD Inc. is the originator. The local marketing authorisation holder may differ — check the official source linked above.